Review
Accepted on 26 Sep 2025
Rheumatoid Arthritis-associated Depression: Focusing on the Interactions between Mitochondria and Endoplasmic Reticulum
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1549060
Type at least 3 characters
2,543 articles
Review
Published on 26 Sep 2025
Pharmacological modulation of the gut-brain axis: psychobiotics in focus for depression therapy
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1665419
- 8,079 views
Original Research
Accepted on 25 Sep 2025
Reducing Stress and Alcohol-Related Behaviors by Targeting D1-CRHR1 Receptor Interactions in the Amygdala
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1677510
Original Research
Published on 25 Sep 2025
Stable interindividual differences in modafinil’s effect on vigilance during sleep deprivation
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1607444
- 575 views
Systematic Review
Published on 24 Sep 2025
Efficacy and safety of vesicular monoamine transporter 2 inhibitors for Huntington’s disease chorea based on network meta-analysis
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1637577
- 463 views
Original Research
Published on 24 Sep 2025
Pharmacovigilance study on old drugs repurposed for rare diseases across different indications: the case of fenfluramine
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1682788
- 740 views
Review
Accepted on 23 Sep 2025
Anti-inflammatory Effect of Curcumin on Neurological Disorders: A Narrative Review
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1658115
- 356 views
Original Research
Accepted on 23 Sep 2025
Dopaminergic REST is implicated in the tamoxifen-induced neuroprotection against manganese toxicity in female mice
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1627400
- 224 views
Correction
Accepted on 23 Sep 2025
Correction: Research progress on plant-derived natural compounds regulating the MAPK signaling pathway for the prevention and therapy of Alzheimer’s disease
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1710820
- 149 views
Original Research
Accepted on 23 Sep 2025
Epigallocatechin-3-gallate conjugated with selenium nanoparticles prevents neurological complications in rats exhibiting schizophrenia-like behaviors
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1680380
- 133 views
Review
Published on 23 Sep 2025
Neuroprotective mechanisms of Buyang Huanwu decoction in ischemic stroke
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1620533
- 1,712 views
Original Research
Accepted on 22 Sep 2025
Ferulic Acid Mitigates 3-Nitropropionic Acid-Induced Huntington's Disease via Modulation of Nrf2/HO-1, TLR4/NF-κB, and SIRT1/p53 Signaling Pathways
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1678724
- 345 views
Original Research
Published on 22 Sep 2025
Naloxone reversal of the cardiorespiratory depressant effects of opioids and mixtures of opioids and stimulants in rats
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1654791
- 1,037 views
Mini Review
Published on 22 Sep 2025
Paclitaxel-induced cognitive impairment: mechanistic insights
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1684006
- 1,317 views
Original Research
Published on 22 Sep 2025
Clinical predictors and concomitant antiseizure medications effects on seizure control in relation to plasma cenobamate concentration: a multicenter retrospective study
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1668382
- 600 views
Original Research
Accepted on 19 Sep 2025
Desensitization of TRPA1 by Dimethyl Itaconate attenuates Acute and Chronic Pain in mice
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1671461
- 592 views